The purpose of this study is to evaluate if TD-4208, an investigational drug being developed to treat people with chronic obstructive pulmonary disease (COPD), has any effect on the electrical activity of the heart.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
48
Celerion
Tempe, Arizona, United States
Change-from-baseline in corrected QT
Time frame: Predose to 24 hours postdose
Maximum Plasma Concentration Cmax
Time frame: Predose to 24 hours postdose
Adverse Events
Time frame: Predose to 24 hours postdose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
oral